Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Fatigue × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 33 Neoplasms, Plasma Cell 10 Prostatic Neoplasms 3 Immunoglobulin Light-chain Amyloidosis 3 Central Nervous System Neoplasms 3 Waldenstrom Macroglobulinemia 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Amyloidosis 2 Adenocarcinoma of Lung 2 Renal Insufficiency, Chronic 1 Renal Insufficiency 1 Polyneuropathies 1 Paraproteinemias 1 Neurotoxicity Syndromes 1 Motor Activity 1 Melanoma 1

Interventions

Modafinil 12 Methylphenidate 6 Surveys and Questionnaires 5 Yoga 4 Educational Status 3 Ultraviolet Therapy 2 Palliative Care 2 Donepezil 2 Dexamethasone 2 Calcium Dobesilate 2 Asian ginseng 2 Acceptance and Commitment Therapy 2 testosterone enanthate 1 testosterone 17 beta-cypionate 1 regorafenib 1 ofatumumab 1 exemestane 1 eicosapentaenoic acid ethyl ester 1 eicosapentaenoic acid ethanolamide 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 coenzyme Q10 1 caffeine, sodium benzoate drug combination 1 auricularum 1 Vitamin E 1 Triptorelin Pamoate 1 Transcranial Direct Current Stimulation 1 Therapeutics 1 Therapeutic Touch 1 Thalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00379353 2013-02-04

The Effects of Thalidomide on Symptom Clusters

M.D. Anderson Cancer Center

Phase 2 Completed

32 enrolled 14 charts

Anorexia, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡